EGR1 acts as an anti-oncogene engaging in multiple cancer processes, including cancer cell proliferation, apoptosis, and migration and even affects tumor microenvironment (Li et al., 2019; Tang et al., 2019). This evidence concerns the gene EGR1 and cancer.